Freelite now in Chinese Multiple Myeloma guidelines
The polyclonal Freelite assay is now included in the Chinese Multiple Myeloma Diagnosis and Treatment Guidelines.
These guidelines recommend serum free light chains in Multiple Myeloma for diagnosis, as a prognostic indicator, to assess response, and for follow-up monitoring to predict disease progression. Two of the authors, Professor Hou Jian and Dr Du Juan, recommend all hospital units to routinely use serum free light chains. A summary of the guidelines by these two authors specifically recommend the use of a polyclonal assay.
These guidelines are published by the Chinese Medical Association and Chinese Myeloma Working Group and were updated in September 2013. They were written by 17 Key Opinion Leaders from 14 different hospitals.
Freelite is a rapid, quantitative assay that measures kappa (κ) and lambda (λ) immunoglobulin free light chains in Multiple Myeloma. These values can be expressed as a κ/λ free light chain ratio.
Download your free copy of the Chinese Myeloma Guidelines (in Chinese)
Learn why the polyclonal Freelite assay is recommended – Download Freelite eBook